BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11881537)

  • 21. [Platinum complexes in cancer pharmacy. Individual patient cytostatic preparation].
    Warnke U
    Pharm Unserer Zeit; 2006; 35(2):110-6. PubMed ID: 16583564
    [No Abstract]   [Full Text] [Related]  

  • 22. Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy.
    Galsky MD; Seng S; Camacho LH; Chiorean EG; Mulkerin D; Hong DS; Oh WK; Bajorin DF
    Clin Genitourin Cancer; 2011 Sep; 9(1):27-30. PubMed ID: 21700509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Satraplatin for the therapy of castration-resistant prostate cancer.
    Sonpavde G; Sternberg CN
    Future Oncol; 2009 Sep; 5(7):931-40. PubMed ID: 19792961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboplatin (JM-8, CBDCA). A new platinum compound.
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):1-48. PubMed ID: 2655092
    [No Abstract]   [Full Text] [Related]  

  • 25. Platinum compounds.
    Belani CP; Van Echo DA; Aisner J
    Curr Opin Oncol; 1989 Dec; 1(2):186-91. PubMed ID: 2489958
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Aug; 13(8):1116-8. PubMed ID: 10499245
    [No Abstract]   [Full Text] [Related]  

  • 27. Cisplatin and new platinum analogs.
    Zwelling LA
    Cancer Chemother Biol Response Modif; 1987; 9():71-80. PubMed ID: 3079417
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and pharmacokinetic evaluation of satraplatin.
    Doshi G; Sonpavde G; Sternberg CN
    Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):103-11. PubMed ID: 22098065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials referral resource. Clinical trials of single-agent oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Jul; 13(7):966, 969-70. PubMed ID: 10442343
    [No Abstract]   [Full Text] [Related]  

  • 30. Platinum compounds in children with cancer: toxicity and clinical management.
    Ruggiero A; Trombatore G; Triarico S; Arena R; Ferrara P; Scalzone M; Pierri F; Riccardi R
    Anticancer Drugs; 2013 Nov; 24(10):1007-19. PubMed ID: 23962902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin.
    Betcher DL; Burnham N
    J Assoc Pediatr Oncol Nurses; 1988; 5(4):29-30. PubMed ID: 3060593
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of a phase-I clinical study of carboplatin--(cyclobutane-1,1-dicarboxylate)diamineplatinum (II)].
    Gorbunova VA
    Vestn Akad Med Nauk SSSR; 1986; (5):45-7. PubMed ID: 3524054
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of satraplatin in dogs with spontaneously occurring malignant tumors.
    Selting KA; Wang X; Gustafson DL; Henry CJ; Villamil JA; McCaw DL; Tate D; Beittenmiller M; Garnett C; Robertson JD
    J Vet Intern Med; 2011; 25(4):909-15. PubMed ID: 21564292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian trials at the Royal Marsden.
    Wiltshaw E
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():67-71. PubMed ID: 3910224
    [No Abstract]   [Full Text] [Related]  

  • 35. [Overview of development status and clinical action. Cisplatin and its analogues].
    Voigt W; Dietrich A; Schmoll HJ
    Pharm Unserer Zeit; 2006; 35(2):134-43. PubMed ID: 16583567
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical status of carboplatin.
    Canetta R; Franks C; Smaldone L; Bragman K; Rozencweig M
    Oncology (Williston Park); 1987 Jul; 1(5):61-70. PubMed ID: 3079484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Satraplatin Demonstrates High Cytotoxic Activity Against Genetically Defined Lymphoid Malignancies.
    Zander T; Xue J; Markson G; Dahm F; Renner C
    Anticancer Res; 2022 Apr; 42(4):1821-1832. PubMed ID: 35347000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
    [No Abstract]   [Full Text] [Related]  

  • 39. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 40. [Platinum-based antineoplastic agents: biomedical applications and therapeutic aspects].
    Dominici C; Petrucci F; Alimonti A; La Torre F; Cifani A; Caroli S
    Ann Ist Super Sanita; 1995; 31(2):289-94. PubMed ID: 8561393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.